Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Xetra  >  Allianz SE    ALV   DE0008404005

SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector newsTweets 

European shares retreat after week of gains; Allianz rallies after update

share with twitter share with LinkedIn share with facebook
share via e-mail
0
02/17/2017 | 11:42am CET
A plastic bull figurine, symbol of the Frankfurt stock exchange is pictured in front of the German share price index DAX board at the Frankfurt stock exchange

European shares fell on Friday with gains in insurance heavyweight Allianz (>> Allianz SE) and firmer pharma stocks more than offset by a pull-back in banking and mining stocks.

European shares fell on Friday with gains in insurance heavyweight Allianz (>> Allianz SE) and firmer pharma stocks more than offset by a pull-back in banking and mining stocks.

The pan-European STOXX 600 <.STOXX> index fell 0.5 percent but remained close to a 13-month high reached on Wednesday and on track to end higher for the second week in a row.

The rally has been fuelled by strong earnings updates, a pick up in merger and acquisition (M&A) activity, with cyclical stocks such as mining companies and banks lifted by solid economic data.

Allianz rose 2.4 percent. Europe's largest insurer proposed spending 3 billion euros on buying back its own shares after posting higher-than-expected profits and saying it was adjusting its policy on budgeting for possible takeovers.

The Munich-based firm also raised its dividend.

"The combination of a dividend increase and a share buy-back probably both at the upper end of market expectations is a sign of strength and should improve sentiment and provide tailwind for the shares," DZ Bank analyst Thorsten Wenzel said.

Elsewhere in the insurance sector, Dutch insurer Aegon (>> AEGON) rose as much as 4.2 percent as investors cheered to a stronger than expected pretax profit growth. Its shares pared gains and were last up 0.3 percent.

On the M&A front, Stada (>> STADA Arzneimittel AG) was once again in focus after the German generic drugs company said it had received its third takeover approach, valuing the company at 58 euros per share, above its current market value and higher than a previous takeover offer. Its shares rose 1.1 percent.

Some big drugmaker stocks were also in demand, lifting the healthcare index <.SXDP> up slightly and making it the only sectoral gainer in Europe.

Britain's AstraZeneca (>> AstraZeneca plc) and GlaxoSmithKline (>> GlaxoSmithKline plc) were up 1.6 percent and 0.5 percent respectively after analysts at Jefferies raised the price target for both.

Europe's STOXX bank index <.SX7P> fell 1.2 percent as investors booked profits for a second day after the index hit a three-week high on Wednesday, helped by growing expectations of a rate hike next month in the United States.

Deutsche Bank (>> Deutsche Bank AG), Standard Chartered (>> Standard Chartered PLC) and Credit Agricole (>> Crédit Agricole) fell between 2.6 and 2.8 percent.

Miners <.SXDP> were also weaker, down 1.1 percent, pulling back after climbing earlier this week to their highest level in more than two years. Copper slid on Friday because of some profit taking, but the likelihood of strong demand from top consumer China were expected to support prices.

"Short-term technicals remain in overbought territory making rounds of profit-taking...more likely," said Markus Huber, trader at City of London Markets.

Top loser on the STOXX was Vopak (>> Koninklijke Vopak), down 8.7 percent, after the Dutch oil and chemical storage company said it did not expect core profit to grow this year.

(Reporting by Danilo Masoni; Editing by Angus MacSwan)

By Danilo Masoni

share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on ALLIANZ SE
02/17 ALLIANZ : Bond giant Pimco sees positive fourth-quarter inflows, strong start to..
02/17DJALLIANZ : Bumper Buyback Shows Insurer's Strength
02/17 Allianz plays down talk of big deals as hands cash to investors
02/17 European shares retreat after week of gains; Allianz rallies after update
02/17DJALLIANZ : Shares Lifted by Strong Results, Share Buyback
02/16DJALLIANZ : to Boost Dividend, Buy Back Shares -- Update
02/16 ALLIANZ : plans three billion-euro share buyback after rise in profits
02/16DJALLIANZ : Sees Stable Profit for 2017
02/16 ALLIANZ : Quarterly and Full Year Earnings Release 2016
02/16 ALLIANZ : 2016 operating profit near upper end of target range
More news
Sector news : Multiline Insurance & Brokers - NEC
02/17 Lloyd's of London set to nominate Carnegie-Brown as chairman - source
02/16DJAIG Reins In Goals, Hitting Stock -- WSJ
02/16DJAfter Earnings Miss, AIG Scales Back Profit Goals
02/15 European bank shares climb to three-week high in earnings-driven trade
02/15DJAMERICAN INTERNATIONAL : AIG Posts Loss on Higher Reserves -- WSJ
More sector news : Multiline Insurance & Brokers - NEC
News from SeekingAlpha
02/17 Allianz's (AZSEY) CEO Oliver Bäte on Q4 2016 Results - Earnings Call Transcri..
02/17 Allianz SE ADR 2016 Q4 - Results - Earnings Call Slides
02/17 Allianz reports Q4 results
01/24 Generali Woes Defy Easy M&A Solution
2016 ALLIANZ SE : A Great Dividend Stock
Advertisement
Financials (€)
Sales 2017 113 659 M
EBIT 2017 10 165 M
Net income 2017 6 871 M
Debt 2017 -
Yield 2017 4,73%
P/E ratio 2017 10,81
P/E ratio 2018 10,39
Capi. / Sales 2017 0,65x
Capi. / Sales 2018 0,64x
Capitalization 74 400 M
More Financials
Chart ALLIANZ SE
Duration : Period :
Allianz SE Technical Analysis Chart | ALV | DE0008404005 | 4-Traders
Full-screen chart
Technical analysis trends ALLIANZ SE
Short TermMid-TermLong Term
TrendsNeutralBullishBullish
Technical analysis
Income Statement Evolution
More Financials
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 32
Average target price 169 €
Spread / Average Target 3,9%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
Oliver Bäte Chief Executive Officer
Helmut Perlet Chairman-Supervisory Board
Christof Mascher Chief Operating Officer
Dieter Wemmer Chief Financial Officer
Wulf H. Bernotat Co-Vice Chairman-Supervisory Board
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
ALLIANZ SE3.69%78 959
AMERICAN INTERNATIONAL..-4.30%64 196
CHUBB LTD3.08%63 375
ZURICH INSURANCE GROUP..-0.64%42 122
MARSH & MCLENNAN COMPA..8.77%37 906
POWER FINANCIAL CORP5.79%19 380
More Results